APA (7th ed.) Citation

Zhou, C., Jiang, J., Guo, L., Xi, W., Wu, J., Cai, Q., . . . Zhang, J. (2025). Lenvatinib Plus Paclitaxel as Second‐Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study. Advanced Science, 12(40), 1. https://doi.org/10.1002/advs.202506678

Chicago Style (17th ed.) Citation

Zhou, Chenfei, Jinling Jiang, Liting Guo, Wenqi Xi, Junwei Wu, Qu Cai, Jun Ji, Feng Qi, and Jun Zhang. "Lenvatinib Plus Paclitaxel as Second‐Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study." Advanced Science 12, no. 40 (2025): 1. https://doi.org/10.1002/advs.202506678.

MLA (9th ed.) Citation

Zhou, Chenfei, et al. "Lenvatinib Plus Paclitaxel as Second‐Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study." Advanced Science, vol. 12, no. 40, 2025, p. 1, https://doi.org/10.1002/advs.202506678.